AN ACT AUTHORIZING THE STATE TO IMPORT THE ACTIVE INGREDIENTS OF CERTAIN DRUGS.

This bill would authorize Connecticut to import the raw materials (active ingredients) needed to produce specific reproductive health medications, including levonorgestrel, mifepristone, and misoprostol. It directly affects state healthcare access by enabling the government to secure these essential drug components. The key provision amends state law to permit the importation of these active ingredients, ensuring their availability for use in Connecticut's healthcare system. The bill focuses on practical access to medications, not on altering their use or distribution.